You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

HYPAQUE SODIUM 20% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hypaque Sodium 20%, and when can generic versions of Hypaque Sodium 20% launch?

Hypaque Sodium 20% is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in HYPAQUE SODIUM 20% is diatrizoate sodium. There are eleven drug master file entries for this compound. Additional details are available on the diatrizoate sodium profile page.

Summary for HYPAQUE SODIUM 20%
Drug patent expirations by year for HYPAQUE SODIUM 20%
Recent Clinical Trials for HYPAQUE SODIUM 20%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institute of Liver and Biliary Sciences, IndiaN/A

See all HYPAQUE SODIUM 20% clinical trials

US Patents and Regulatory Information for HYPAQUE SODIUM 20%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare HYPAQUE SODIUM 20% diatrizoate sodium SOLUTION;URETERAL 009561-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.